title: Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers.
authors.affiliation: Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: psutka.sarah@mayo.edu.
authors.forename: Sarah P
authors.initials: SP
authors.lastname: Psutka
authors.affiliation: Department of Urology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Igor
authors.initials: I
authors.lastname: Frank
authors.affiliation: Department of Urology, Mayo Clinic, Rochester, MN, USA.
authors.forename: R Jeffrey
authors.initials: RJ
authors.lastname: Karnes
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000469:Alkaline Phosphatase / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D001859:Bone Neoplasms / Q000556:secondary*; D003661:Decision Support Techniques; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D014408:Biomarkers, Tumor; D000469:Alkaline Phosphatase